文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

高分子量透明质酸——腹腔脓毒症液体复苏的潜在辅助剂?

HIGH-MOLECULAR-WEIGHT HYALURONAN-A POTENTIAL ADJUVANT TO FLUID RESUSCITATION IN ABDOMINAL SEPSIS?
PubMed 文献 · Shock · 2023-02-22
一句话结论猪腹膜炎脓毒症模型中,辅助透明质酸未减少复苏液体量或减轻炎症反应(P=0.442)。

该研究为前瞻性、平行分组、盲法猪腹膜炎脓毒症模型,将动物随机分为辅助透明质酸组(标准治疗加用,n=8)或0.9%盐水组(n=8)。血流动力学不稳定后,先给予0.1%透明质酸(1 mg/kg/10 min)或安慰剂(0.9%盐水)负荷,随后持续输注0.1%透明质酸(1 mg/kg/h)或盐水。结果显示,干预组与对照组总静脉液体量分别为17.5 ± 11 vs 19.0 ± 7 mL/kg/h(P=0.442),血浆IL-6在复苏18小时分别为2,450(1,420-6,890)pg/mL与3,690(1,410-11,960)pg/mL(无显著差异)。干预逆转了腹膜炎脓毒症相关的透明质酸碎片比例增加(复苏18小时平均峰洗脱分数:干预组16.8 ± 0.9 vs 对照组17.9 ± 0.6,P=0.031)。结论:透明质酸未减少液体复苏所需容量或减轻炎症反应,尽管它平衡了腹膜炎诱导的透明质酸碎片比例增加。

要点

  • 猪腹膜炎脓毒症模型中,辅助透明质酸未减少复苏液体量:干预组17.5 ± 11 vs 对照组19.0 ± 7 mL/kg/h(P=0.442)。
  • 复苏18小时血浆IL-6干预组2,450(1,420-6,890)pg/mL vs 对照组3,690(1,410-11,960)pg/mL,无显著差异。
  • 干预逆转腹膜炎脓毒症相关的透明质酸碎片比例增加:复苏18小时平均峰洗脱分数干预组16.8 ± 0.9 vs 对照组17.9 ± 0.6(P=0.031)。
  • 液体复苏目标为每搏量变异度<13%。
  • 透明质酸给药方案:0.1%透明质酸1 mg/kg/10 min负荷,随后1 mg/kg/h持续输注。

适用人群与场景

  • 猪腹膜炎脓毒症模型,血流动力学不稳定后开始干预。

诊断标准与关键阈值

  • 液体复苏目标为每搏量变异度<13%。

处置流程与药物剂量

  • 血流动力学不稳定后,先给予0.1%透明质酸1 mg/kg/10 min(干预组)或安慰剂0.9%盐水负荷。
  • 随后持续输注0.1%透明质酸1 mg/kg/h(干预组)或盐水,直至实验结束。

研究设计与关键结果

  • 前瞻性、平行分组、盲法猪腹膜炎脓毒症模型,随机分为辅助透明质酸组(n=8)或0.9%盐水组(n=8)。
  • 总静脉液体量:干预组17.5 ± 11 vs 对照组19.0 ± 7 mL/kg/h(P=0.442)。
  • 复苏18小时血浆IL-6:干预组2,450(1,420-6,890)pg/mL vs 对照组3,690(1,410-11,960)pg/mL(无显著差异)。
  • 复苏18小时平均峰洗脱分数:干预组16.8 ± 0.9 vs 对照组17.9 ± 0.6(P=0.031)。

证据类型、等级与局限

  • 证据类型:前瞻性、平行分组、盲法动物实验(猪腹膜炎脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,透明质酸未减少液体复苏所需容量或减轻炎症反应,尽管它平衡了腹膜炎诱导的透明质酸碎片比例增加。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

While fluid resuscitation is fundamental in the treatment of sepsis-induced tissue hypoperfusion, a sustained positive fluid balance is associated with excess mortality. Hyaluronan, an endogenous glycosaminoglycan with high affinity to water, has not been tested previously as adjuvant to fluid resuscitation in sepsis. In a prospective, parallel-grouped, blinded model of porcine peritonitis sepsis, we randomized animals to intervention with adjuvant hyaluronan (add-on to standard therapy, n = 8) or 0.9% saline (n = 8). After the onset of hemodynamic instability, the animals received an initial bolus of 0.1% hyaluronan (1 mg/kg/10 min) or placebo (0.9% saline) followed by a continuous infusion of 0.1% hyaluronan (1 mg/kg/h) or saline during the experiment. We hypothesized that the administration of hyaluronan would reduce the volume of fluid administered (aiming at stroke volume variation <13%) and/or attenuate the inflammatory reaction. Total volumes of intravenous fluids infused were 17.5 ± 11 versus 19.0 ± 7 mL/kg/h in intervention and control groups, respectively ( P = 0.442). Plasma IL-6 increased to 2,450 (1,420-6,890) pg/mL and 3,690 (1,410-11,960) pg/mL (18 hours of resuscitation) in the intervention and control groups (nonsignificant). The intervention counteracted the increase in proportion of fragmented hyaluronan associated with peritonitis sepsis (mean peak elution fraction [18 hours of resuscitation] intervention group: 16.8 ± 0.9 versus control group: 17.9 ± 0.6 [ P = 0.031]). In conclusion, hyaluronan did not reduce the volume needed for fluid resuscitation or decrease the inflammatory reaction, even though it counterbalanced the peritonitis-induced shift toward increased proportion of fragmented hyaluronan.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Barrueta Tenhunen A, van der Heijden J, Dogné S, et al. HIGH-MOLECULAR-WEIGHT HYALURONAN-A POTENTIAL ADJUVANT TO FLUID RESUSCITATION IN ABDOMINAL SEPSIS? Shock. 2023. PMID: 36809365. doi:10.1097/SHK.0000000000002089

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。